Life Science News

Latest updates from the biotech and pharma world

BioPharma Dive 2026-01-09

Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies

BioPharma Dive 2026-01-09

Aktis raises $318M in 2026’s first biotech IPO

BioPharma Dive 2026-01-08

Alveus launches with $160M to advance MariTide-like obesity drug

BioPharma Dive 2026-01-08

Parabilis, chasing ‘undruggable’ targets, nabs $305M amid VC funding blitz

BioPharma Dive 2026-01-08

Diagonal banks another $125M for ‘clustering’ antibody drugs

BioPharma Dive 2026-01-08

EpiBiologics raises $107M for its protein-degrading cancer drug

BioPharma Dive 2026-01-07

Lilly snaps up Ventyx for $1.2B in pursuit of oral immune drugs

BioPharma Dive 2026-01-07

GSK, Ionis claim study success for RNA-based hepatitis B drug

BioPharma Dive 2026-01-07

Arrowhead showcases early obesity data; Instil bails on PD-1/VEGF drug

BioPharma Dive 2026-01-07

5 FDA decisions to watch in the first quarter of 2026

BioPharma Dive 2026-01-06

Alumis soars as TYK2 drug hits mark in psoriasis trials

BioPharma Dive 2026-01-06

Amgen buys protein-degrading startup Dark Blue for up to $840M

BioPharma Dive 2026-01-06

CDC, following Trump’s orders, weakens US stance on childhood vaccinations

BioPharma Dive 2026-01-05

Surfing the AI wave: How pharma can harness agents in ERP

BioPharma Dive 2026-01-05

Moderna, searching for a rebound, to seek approval of mRNA flu shot

BioPharma Dive 2026-01-05

Zenas shares crash after top drug misses expectations in immune disease study

BioPharma Dive 2026-01-05

Novo launches Wegovy pill; Argenx to swap CEOs

BioPharma Dive 2026-01-05

10 clinical trials to watch in the first half of 2026

BioPharma Dive 2026-01-05

Strategic diagnostic testing partnerships are accelerating clinical research

BioPharma Dive 2025-12-23

Novo Nordisk’s weight loss pill approved by FDA

2 / 7